RE: Li Ka-shing’s CK Life unit eyes China fast track for cancer vaccine pipeline28 May 2026 12:26
I don't think the biotech backdrop has ever been this bullish, especially around China but listed companies are getting walloped ?
'Global pharmaceutical corporations “need to have a Chinese strategy”, said Stephen Farrelly, managing director and global lead for pharmaceutical and healthcare at ING, a Dutch financial services group overseeing about US$15 billion in pharmaceutical and healthcare assets globally.
“It can be a partner, or it can be [competition], but you cannot be passive because this market is evolving at the speed that you simply must pay attention to it.”
The “NewCo” model – where financial sponsors acquire Chinese drug assets and spin them into stand-alone companies for overseas development – had emerged as a growing way for Chinese biotech firms to expand globally, according to a May report by L.E.K. Consulting. Deal activity increased from two in 2024 to 16 in 2025, accounting for about 12 per cent of out-of-China licensing deals by value last year.
https://www.scmp.com